A Phase II Study of Ibrutinib, Rituximab and mini-CHOP therapy in very elderly patients with newly diagnosed DLBCL

DOI number 10.58109/3xdt-2v79
Publisher Australasian Leukaemia and Lymphoma Group (ALLG)

Australasian Leukaemia and Lymphoma Group (ALLG)

Judith Trotman (Concord Hospital)

Date Made Available 2023
Dataset Individual participant data (IPD) in aggregate form
Description of Dataset

Dataset includes:

  • Data for 80 patients aged >75 years
  • Treatment of Elderly patient cohort with newly diagnosed Diffuse large B cell lymphoma (DLBCL) with Ibrutinib, Rituximab and mini-CHOP therapy
  • Demographic data
  • Diagnostic, data
  • Treatment data
  • Outcome data

Australasian Leukaemia and Lymphoma Group (ALLG)

Subject (ANZSRC Category)


ANZCTR Reference ACTRN12615000551594
Dataset Access

Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with this trial or email enquiries to info@allg.org.au